AptarGroup (ATR) Stock: Buy, Sell, or Hold?
ATR - AptarGroup, Inc.
$120.87
-0.29 (-0.24%)
▼
5d:
-2.03%
30d:
-7.68%
90d:
-4.81%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 29, 2026
26d
Get Alerted When ATR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ATR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ATR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$201.04
Based on 9.2% avg growth
INTRINSIC VALUE TODAY
$124.83
3.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATR is currently trading at $120.87, which is considered oversold relative to its 30-day fair value range of $122.43 to $131.02. The stock's valuation (Forward PE: 19.2) is in line with its historical norms (20.6). Remarkably, the market is currently pricing in an annual earnings decline of 2.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATR is in a uptrend. The price is currently testing key support at $119.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $170.14 (+40.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATR is in a uptrend. The price is currently testing key support at $119.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $170.14 (+40.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$122.43 -
$131.02
Company Quality Score
55/100
(HOLD)
Options IV Signal
34th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding ATR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 34th percentile)
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.8% below Wall St target ($170.14)
Trading Range Analysis
30-Day Trading Range
$122.43 -
$131.02
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$4.64
(3.8%)
Support & Resistance Levels
Support Level
$119.22
Resistance Level
$125.98
Current Trend
Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.18
Wall Street Target
$170.14
(+40.8%)
Revenue Growth (YoY)
6.3%
Earnings Growth (YoY)
-18.6%
Profit Margin
9.2%
Valuation Discount vs History
-2.4% cheaper
PE vs Historical
19.2 vs 20.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.4%
(market-implied from PE analysis)
1-Year Target
$117.97
(-2%)
2-Year Target
$115.14
(-5%)
3-Year Target
$112.37
(-7%)
3-Yr Target (if PE normalizes)
(PE: 19→21)
$120.71
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 14.4%)
$192.46
(+59%)
Base:
(SPY PE: 19.2, Growth: 14.4%)
$180.92
(+50%)
Bear:
(PE: 16.3, Growth: 14.4%)
$153.78
(+27%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 21.87 | Current EPS (TTM): $5.54
Bull Case
$151.63
(+25%)
Analyst growth 13.8%, PE expands to 24.1
Base Case
$137.84
(+14%)
Market implied 13.8%, PE stable at 21.9
Bear Case
$82.39
(-32%)
Severe decline -20.0%, PE contracts to 18.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.2 to 20.6
Stabilization Target:
$129.84
(+7.4%)
PE Expansion Potential:
+7.4%
Share & Embed Analysis
Last updated: October 02, 2026 3:45 AM ET
Data refreshes hourly during market hours. Next update: 4:45 AM
Data refreshes hourly during market hours. Next update: 4:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 50 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 33 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 58 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$408 | 52 HOLD |
Advanced ATR Option Strategies
Professional options setups generated by AI based on today's ATR price and gamma walls.
